Cargando…
Precision renal medicine: a roadmap towards targeted kidney fibrosis therapies
Based on extensive pre-clinical achievements over the past decades, it appears to be due time for a successful clinical translation in the renal fibrosis field—but what is the quickest road to get there? In light of the recent launch of the Precision Medicine Initiative and success of molecularly in...
Autores principales: | Zeisberg, Michael, Zeisberg, Elisabeth M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556008/ https://www.ncbi.nlm.nih.gov/pubmed/26330891 http://dx.doi.org/10.1186/s13069-015-0033-x |
Ejemplares similares
-
Different Patterns of Kidney Fibrosis Are Indicative of Injury to Distinct Renal Compartments
por: Tampe, Désirée, et al.
Publicado: (2021) -
CRISPR/Cas Derivatives as Novel Gene Modulating Tools: Possibilities and In Vivo Applications
por: Xu, Xingbo, et al.
Publicado: (2020) -
High-fidelity CRISPR/Cas9- based gene-specific hydroxymethylation rescues gene expression and attenuates renal fibrosis
por: Xu, Xingbo, et al.
Publicado: (2018) -
Serelaxin alleviates cardiac fibrosis through inhibiting endothelial-to-mesenchymal transition via RXFP1
por: Wilhelmi, Tim, et al.
Publicado: (2020) -
DNMT1 and HDAC2 Cooperate to Facilitate Aberrant Promoter Methylation in Inorganic Phosphate-Induced Endothelial-Mesenchymal Transition
por: Tan, Xiaoying, et al.
Publicado: (2016)